Our President and CEO Prahlad Singh recently joined Jim Cramer on CNBC’s Mad Money to describe how agility and innovation continue to fuel PerkinElmer's transformation. In this interview, Prahlad talked about the Company's recent acquisitions and future opportunities in the Life Sciences and Diagnostics sectors.
Click below to watch a video. If the video is by one of our media partners, you will be taken to their site.
Prahlad Singh, President and CEO of PerkinElmer, sat down with This Week in Business on NECN to talk about the Company’s COVID-19 RT-PCR and antigen tests, and how he perceives the COVID-19 testing landscape to be as vaccines roll out.
Masoud Toloue, Senior Vice President of PerkinElmer Diagnostics, talked with 7News in Boston about PerkinElmer’s antigen test that detects SARS-CoV-2 nucleocapsid antigen in under 15 minutes. The test is expected to play an important role in point-of-care testing located at healthcare centers, travel hubs, businesses and schools.
Our Head of Food, Greg Sears, talks with New Food about trends in food testing and quality, as well as how PerkinElmer’s solutions can help customers meet food and cannabis regulations.
Innovative private-public partnership with PerkinElmer will soon allow California to process an additional 150,000 COVID-19 tests a day.
PerkinElmer CEO Prahlad Singh joined Jim Cramer on CNBC’s Mad Money to discuss the how the company’s unique, comprehensive turnkey solutions help in the fight against COVID-19.
Lead scientist of the eXXpedition research boat Dr. Winnie Courtene-Jones shares how the portable and powerful Spectrum Two FT/IR Spectrometer is being used on board to test for microplastics in our oceans.
Have you ever thought AI can help diagnose genetic disorders? A Boston company is helping clinicians narrow down a patient’s diagnosis out of thousands of disorders with facial recognition technology.
In this video, Justin Waldron of EUROIMMUN provides an overview of the high-capacity EUROLabWorkstation at AACC 2019.